巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Evogene Ltd

    EVGN
    0.902
    0.010
    1.01%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Evogene Ltd - 延遲價格・最後更新於 20/05 12:15
    最高位
    0.926
    最低位
    0.890
    開市價
    --
    前收市價
    0.912
    成交量(千)
    1.18
    成交額(百萬)
    0.01
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    37.16
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    4.100 - 0.810
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Evogene Ltd
    證券代碼
    EVGN.US
    所屬板塊
    Biotechnology
    公司業務
    Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.
    發行量
    41188280
    公司總部
    13 Gad Feinstein Street, Park Rehovot, P.O. Box 4173, Ness Ziona
    公司網址
    https://www.evogene.com
    公司電郵
    ir@evogene.com
    公司電話
    +972 89311900
    暫無內容

    關於

    Evogene Ltd(EVGN.US)所屬的行業板塊為Biotechnology。
    Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.
    詳細公司背景可參考: https://www.evogene.com